research Efficacy of modern methods for assessing the severity of alopecia areata
The SBN system effectively assesses alopecia areata severity and predicts its course.
Search
for
Sort by
Research
60-90 / 1000+ results
research Treatment of moderate-to-severe alopecia areata in patients over the age of 65 with baricitinib
Baricitinib helps treat severe hair loss in people over 65.
research Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients
research REVIEW OF MODERN METHODS OF TREATMENT OF LICHEN PLANUS OF THE ORAL MUCOSA
New, safer, and personalized treatments are needed for oral lichen planus.
research Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.
research Use of modern technological devices (photography, mobile phone applications and artificial intelligence) in dermatology
Technology, like mobile apps and AI, is improving skin condition diagnosis and treatment.
research [Treatment of moderately severe virilism of women with Diane and Androcur 10].
Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.
research Androgenetic alopecia : modern concepts of pathogenesis and treatment
Hair can regrow if the sebaceous gland is intact, even if the hair root is removed.
research A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
Apremilast was not effective in treating moderate-to-severe alopecia areata.
research Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.
research Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.
research Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.
research High-resolution stable isotope profiles of modern elephant (Loxodonta africana) tusk dentin and tail hair from Kenya: Implications for identifying seasonal variability in climate, ecology, and diet in ancient proboscideans
Elephant tusks and hair reveal seasonal diet and climate changes.
research Towards grizzly bear population recovery in a modern landscape
Grizzly bear conservation success requires public support and understanding of scientific findings on population monitoring and habitat impact.
research Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.
research Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.
research Efficacy Observation on Mild to Moderate Active Systemic Lupus Erythematosus Treated with Compound Zishenqing Formula
The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.
research Depression Risk in the Treatment of Moderate to Severe Acne with Isotretinoin
No proven link between isotretinoin and depression.
research THE KAINAR SYNDROME : HISTORY AND MODERN UNDERSTANDING
Kainar syndrome symptoms may be linked to nuclear test exposure effects.
research Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients
Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.
research SCIENTISTS AND METHODS OF USING MODERN TECHNOLOGIES
research 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.
research Clinical and Haemodynamic Study of Minoxidil in Moderately Hypertensive Patients
Minoxidil with a diuretic effectively lowers blood pressure in moderately hypertensive men with minimal side effects.
research Health-related quality of life in mild-moderate patchy alopecia areata: Results from the first controlled Phase 2 clinical trial in this population with STS01 (dithranol/ProSilic) and challenges for the future
Hair regrowth improved, but quality of life did not.
research Hair and Scalp Health in Modern Lifestyle: Challenges and Natural Solutions
Consistent use of natural methods is key for healthy hair and scalp.
research INTEGRATIVE APPROACH TO KHALITYA: BRIDGING AYURVEDA AND MODERN SCIENCE
Dietary habits and stress management are key to preventing hair loss.
research INTEGRATIVE APPROACH TO KHALITYA: BRIDGING AYURVEDA AND MODERN SCIENCE
Dietary habits and stress management are key to preventing hair loss.
research Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
Hair loss from weight-loss treatments is usually temporary and reversible.
research Efficacy of oral tofacitinib in moderate to severe alopecia areata, totalis and universalis at the tertiary care hospital, Karachi
Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.
research Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.
Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.